CC-486
CC-486-AML-004
Phase 1 small_molecule completed
Quick answer
CC-486 for Leukemia, Myeloid, Acute is a Phase 1 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Leukemia, Myeloid, Acute
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed